© 2021 KOMAND Consulting
Other
Migraine
Depression
Nausea/Vomiting
Anorexia
Spasticity
Pain
1%
2%
3%
4%
7%
11%
72%
GERMANY
Population: 83,019,200
GDP/Capita: USD$53,566
Wholesale Medical Flower Price/Gram: €9.52 (2020)
Pharmacy purchase price from licenced distributor
Current Med/Rec Usage (15-64yrs): 6.1%
Prescription Count Q2-2021 LTM
361,389
Prescription Count 2020
338,135
Manufacturer German Importer/Distributor (80+ in total)
Aphria Inc.
ACA Müller GmbH
Aurora Cannabis Enterprises Inc.
Adrexpharma GmbH
Aurora Nordic Cannabis A/S
alephSana GmbH
Demecan GmbH
Aurora Deutschland GmbH
Peace Naturals Project Inc. (Cronos)
Bathera GmbH
Bedrocan International B.V.
Bava medical GmbH
Fotmer Life Sciences
Cannamedical GmbH
Linneo Health SL
Cannizin Pharma GmbH
Northern Green Canada
Cannovum Health eG
Tilray Portugal
CanPharma GmbH
Tilray Canada Ltd.
Cansativa GmbH
Tweed Inc
Cantourage GmbH
TerrAscend
CC Pharma GmbH
Cannim
canymed GmbH
Demecan GmbH
Fagron GmbH & Co. KG
Farmako GmbH
Four 20 Pharma GmbH
G. Pohl-Boskamp GmbH & Co. KG
Geca Pharma GmbH
Heinrich Klenk GmbH & Co. KG
iuvo Therapeutics GmbH
Lexamed GmbH
Materia Germany GmbH
Medical CNBS Pharma GmbH
Noweda Apothekergenossenschaft KG
Paesel + Lorei GmbH & Co. KG
Phatebo GmbH
Spektrum Cannabis GmbH
Tilray Deutschland GmbH
Vayamed GmbH (Sanity)
Federal Institute for Drugs & Medical Devices (BfArM)
Issues the licenses to cultivate, produce, trade, import, export,
deliver, sell or buy narcotics (pharmaceutical licences). Also publish
the German Pharmacopoeia (Deutsches Arzneibuch, DAB)
The European Medicines Agency
Compliance guidelines for EU GMP, EU GDP & EU GACP,
inspection procedures and forms agreed by all EU Member States
German Medical Cannabis Retail Sales
Trailing 12-Month (Public Insurance Covered)
b
€63.8m
€7.6m
€47.8m
€11.5m
€42.4m
Raw Flower
Flower Preparation
Dronabinol
F.Spectrum Extract
Cannabis Pharma
Drugs
Regulatory Agencies
Patient/Prescription Count
d
e
Deutscher Bundestag Drucksache 19/18292, Mar 2020
Other:
ADHD, Lack of appetite,
Intestinal disease
Tourette's syndrome, epilepsy
Restless Leg Syndrome
Insomnia / sleep disorder
Medicinal Cannabis Flower imported
into Germany
c
2017 2018 2019 2020 H1-2021
1,201 kg
3,129 kg
6,740 kg
8,967 kg
9,321 kg
Sources : European Monitoring Centre for Drugs & Drug Addiction (EMCDDA)
Statistisches Bundesamt, Cannabis Ärzte, IMF
c
BfArM & Bundestag
Medical Cannabis Distribution in Germany
g
k
Cannabis Ärzte, DIMDI für Bürgerinnen und Bürger
Back to Europe
STATUS
Germany provides broad access to medical cannabis without
specific indication requirements
Insurers (both public and private) are required to reimburse
patients for medical cannabis prescriptions, unless a “generally
recognised therapy under medicinal standards is available”
NEWS
German Coalition Looks To Start Europe’s First Adult-Use Cannabis Market
Aurora says its Danish cannabis has reached German pharmacies
STADA enters an exclusive partnership with MediPharm Labs
Status Quo & Recent News
Products
Patients
Gross Sales
€173m
Jun 2021
b
The sales represent the consolidation of all the public insurers, which cover 90% of
the German population (10% are assumed covered by private purchase)
Product Channels
d
The Patient Count is the total population of patients that have been
prescribed medical cannabis at some point since legalisation
Product
Package
Size
Package
Wholesale
Price
Package Retail
Price
Raw flower
Various €9.52/g
€12-14/g
Full spectrum extract (Tilray)
25ml €173
€411
Sativex, oral cavity spray
3 x 10ml €382
€479
Dronabinol (Tilray)
500mg €170
€388
Dronabinol (Marinol)
250mg n/a
€300
Nabilone (Canemes), capsules
28 Capsules
n/a
€467
List of Approved Products - BfArM
a
a
Drug Price Regulation (AMPreisV) #3, #4, #5, gelbe-liste.de, DAZ,
German cannabis experts, doctors and medical staff, cannabis-med
Last Updated – Oct 2021
Q2-2021
Q1-2021
Q4-2020
Q3-2020
Q2-2020
Q1-2020
Q4-2019
Q3-2019
93,334
91,165
90,843
86,047
83,012
78,233
73,886
71,012
Medicinal Cannabis Prescriptions in Germany
by Quarter
f
f
GKV-Arzneimittel-Schnellinformation für Deutschland
Cannabis
Pharma
German Condition/Symptom Percentage by
Patient Prescriptions
e